Copenhagen business journalist convicted of market manipulation

He received a 30-day conditional sentence

A business journalist for the publication Penge og Privatøkonomi has been sentenced to a month in prison for stock market manipulation.

No free market
The journo was convicted of charges of manipulating stock prices in the period from 2011 to 2013 by writing articles that encouraged readers to buy up stocks of small companies as a long-term investment.

He himself bought stocks of the same companies before his pieces were published and then sold them when prices rose as a result of his articles.

Copenhagen City Court on Monday afternoon sentenced the man to a conditional sentence of 30 days.

The prosecution, which had demanded that a fine of 75,000 kroner be levied in the days leading up to the case, had to settle for a much lower one of 10,000 kroner instead.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.